Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
$0.35
$0.35
$0.17
$0.40
$94.74M1.372.03 million shsN/A
Fonar Corporation stock logo
FONR
Fonar
$14.88
+3.2%
$13.52
$12.00
$19.19
$92.26M0.9917,039 shs18,182 shs
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
$2.90
+0.3%
$2.71
$1.92
$4.21
$103.50M0.42248,824 shs77,225 shs
Vaso Corporation stock logo
VASO
Vaso
$0.13
-0.1%
$0.13
$0.11
$0.32
$22.67M1.5534,149 shs142,702 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
0.00%0.00%0.00%0.00%+4.47%
Fonar Corporation stock logo
FONR
Fonar
0.00%+4.94%+3.33%+6.21%-7.00%
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
0.00%+3.20%+18.85%-1.36%+34.88%
Vaso Corporation stock logo
VASO
Vaso
0.00%+1.65%-5.43%-11.03%-56.27%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
N/AN/AN/AN/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
1.7602 of 5 stars
0.03.00.00.03.30.81.9
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
3.0934 of 5 stars
3.82.00.00.03.81.70.6
Vaso Corporation stock logo
VASO
Vaso
0.4886 of 5 stars
0.03.00.00.00.61.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
0.00
N/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
3.50
Strong Buy$5.4086.21% Upside
Vaso Corporation stock logo
VASO
Vaso
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
$8.58M11.04N/AN/A$0.13 per share2.68
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.90$3.07 per share4.84$24.78 per share0.60
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
$370K279.73N/AN/A$0.42 per share6.90
Vaso Corporation stock logo
VASO
Vaso
$86.77M0.26$0.01 per share12.76$0.16 per share0.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
-$78.43M-$0.31N/AN/AN/A-902.25%-184.10%-114.75%N/A
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2511.90N/A8.19%5.31%3.97%N/A
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
-$16.33M-$0.45N/AN/AN/AN/A-115.71%-92.75%8/13/2025 (Estimated)
Vaso Corporation stock logo
VASO
Vaso
$950KN/A0.00N/A1.20%3.93%1.37%8/12/2025 (Estimated)

Latest VASO, MGRM, ASXC, and FONR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
5/15/2025Q1 2025
Vaso Corporation stock logo
VASO
Vaso
N/A-$0.01N/A-$0.01N/A$19.46 million
5/14/2025Q1 2025
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.12-$0.10+$0.02-$0.10N/AN/A
3/31/2025Q4 2024
Vaso Corporation stock logo
VASO
Vaso
N/A$0.01N/A$0.01N/A$27.04 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
N/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
N/AN/AN/AN/AN/A
Vaso Corporation stock logo
VASO
Vaso
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
N/A
1.00
0.69
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
N/A
7.00
7.00
Vaso Corporation stock logo
VASO
Vaso
N/A
1.52
1.49

Institutional Ownership

CompanyInstitutional Ownership
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
9.35%
Fonar Corporation stock logo
FONR
Fonar
50.64%
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
0.45%
Vaso Corporation stock logo
VASO
Vaso
N/A

Insider Ownership

CompanyInsider Ownership
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
2.87%
Fonar Corporation stock logo
FONR
Fonar
1.55%
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
28.10%
Vaso Corporation stock logo
VASO
Vaso
44.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
170272.33 million264.52 millionNot Optionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
2835.69 million25.66 millionNot Optionable
Vaso Corporation stock logo
VASO
Vaso
260175.74 million97.54 millionNot Optionable

Recent News About These Companies

Corn in a Cup (Elote en Vaso)
Vaso Corporation Registered Shs
Top Analyst Reports for Apple, Philip Morris & Sony
Inflammation during menstrual cycle may trigger VOEs: Study
Vasomedical reports Q4 revenue $27M vs. $21.9M last year

New MarketBeat Followers Over Time

Media Sentiment Over Time

Asensus Surgical stock logo

Asensus Surgical NYSEAMERICAN:ASXC

$0.35 0.00 (0.00%)
As of 08/22/2024

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Fonar stock logo

Fonar NASDAQ:FONR

$14.88 +0.46 (+3.19%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$14.50 -0.38 (-2.55%)
As of 08:30 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Monogram Orthopaedics stock logo

Monogram Orthopaedics NASDAQ:MGRM

$2.90 +0.01 (+0.35%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$3.00 +0.10 (+3.45%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

Vaso stock logo

Vaso OTCMKTS:VASO

$0.13 0.00 (-0.08%)
As of 06/27/2025 03:49 PM Eastern

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.